Dose Selection Incorporating PK/PD Information in Early Phase Clinical Trials
Duration: 41 mins 1 sec
About this item
| Description: |
Bogachka, B (QMUL)
Monday 15 August 2011, 16:35-17:15 |
|---|
| Created: | 2011-08-18 08:23 | ||||
|---|---|---|---|---|---|
| Collection: | Design and Analysis of Experiments | ||||
| Publisher: | Isaac Newton Institute | ||||
| Copyright: | Bogachka, B | ||||
| Language: | eng (English) | ||||
| Credits: |
|
||||
| Abstract: | Early phase clinical trials generate information on pharmacokinetic parameters and on safety issues. In addition, a dose level, or a set of dose levels, needs to be selected for further examination in later phases. If patients, rather than healthy volunteers, take part in the early phase, it may be possible to observe the effects of the drug on the disease. In the presentation we will discuss some statistical, ethical and economic aspects of designing optimum adaptive clinical trials for dose selection incorporating both pharmacokinetic and pharmacodynamic endpoints. |
|---|---|
Available Formats
| Format | Quality | Bitrate | Size | |||
|---|---|---|---|---|---|---|
| MPEG-4 Video | 480x360 | 1.84 Mbits/sec | 567.31 MB | View | Download | |
| WebM | 480x360 | 559.33 kbits/sec | 167.76 MB | View | Download | |
| Flash Video | 480x360 | 567.9 kbits/sec | 170.61 MB | View | Download | |
| iPod Video | 480x360 | 505.42 kbits/sec | 151.84 MB | View | Download | |
| QuickTime | 384x288 | 849.09 kbits/sec | 255.08 MB | View | Download | |
| MP3 | 44100 Hz | 125.02 kbits/sec | 37.36 MB | Listen | Download | |
| Windows Media Video | 478.25 kbits/sec | 143.68 MB | View | Download | ||
| Auto * | (Allows browser to choose a format it supports) | |||||
